Viable Age of Newborn in India
In India, as in most developed healthcare settings globally, viability is generally considered to begin at 23-24 weeks of gestation, with meaningful survival rates starting at 23 weeks (23-27% survival) and improving significantly by 24 weeks (42-59% survival) and 25 weeks (67-76% survival). 1
Defining the Periviable Period
The periviable period is defined as delivery occurring from 20 0/7 weeks to 25 6/7 weeks of gestation. 1 This represents the gestational age range where outcomes vary dramatically from near-certain death to likely survival with significant morbidities.
Gestational Age-Specific Outcomes
Before 23 Weeks
- Delivery before 23 weeks typically results in neonatal death (5-6% survival), and among rare survivors, significant morbidity is universal (98-100%). 1
- At 22 weeks of gestation, survival remains extremely poor with no significant benefit from interventions like antenatal corticosteroids. 1
23 Weeks and Beyond
- 23 weeks: 23-27% survival to discharge, with 45% of survivors having severe or moderate impairment at 30 months. 1
- 24 weeks: 42-59% survival to discharge, with 30% of survivors having severe or moderate impairment. 1
- 25 weeks: 67-76% survival to discharge, with 17% of survivors having severe or moderate impairment. 1
Context-Specific Considerations for India
India's Medical Termination of Pregnancy (MTP) Act has been extended to 24 weeks, which creates important legal and clinical distinctions around viability definitions. 2 This legal framework influences how extreme preterm births are classified and managed in the Indian healthcare context. 2
Critical Practice Points
Wide variation exists in practices regarding initiation of resuscitation at 22-23 weeks, and this variation explains significant between-hospital differences in survival and survival without impairment. 1 In resource-limited settings, outcomes may be further compromised.
Recommended Interventions by Gestational Age
At 23 Weeks and Beyond
- Antenatal corticosteroids are recommended as they significantly reduce death and neurodevelopmental impairment (83.4% vs 90.5% at 23 weeks). 1
- Magnesium sulfate for neuroprotection is recommended when periviable delivery of a potentially viable infant is anticipated, as it reduces cerebral palsy risk (relative risk 0.68). 1
At 22 Weeks
- No significant benefit from antenatal corticosteroids has been demonstrated (90.2% vs 93.1% death/impairment). 1
- Resuscitation decisions remain highly individualized with extremely poor prognosis.
Common Pitfalls
Avoid confusing legal abortion limits with clinical viability thresholds - the MTP Act extension to 24 weeks in India does not mean viability begins at 24 weeks; meaningful survival begins at 23 weeks. 2
Accurate gestational age assessment is critical - outcomes at the extremes of each week (e.g., 23 6/7 weeks) may be closer to the adjacent week than to the other extreme of the same week. 1
Neurodevelopmental impairment remains substantial even among survivors - at 23 weeks, 40% of survivors at 4-8 years have moderate-to-severe neurodevelopmental impairment. 1